InvestorsHub Logo
Followers 0
Posts 15
Boards Moderated 0
Alias Born 07/26/2017

Re: West Coast Snapper post# 29364

Monday, 08/14/2017 7:04:17 AM

Monday, August 14, 2017 7:04:17 AM

Post# of 38634
Micro they will have to do more tests on Rexista even if it is tentatively approved, trials for Regabatin and PODRAS as well and cash flow won't cover all of those costs and using shelf will have a negative effect on the PPS.

Legal costs will also be a drain on cash.

My point was only a partnership (s) and hiring an experienced CEO and CFO will save the PPS going much lower, but boost it and add confidence in the company